PTK2 and neoplasm: By comparing samples from the same patients pre- and post-chemotherapy, we found pY397 FAK levels trended significantly upward in tumors surviving neoadjuvant chemotherapy (Figure 3D), further supporting an association between FAK signaling and tumor chemoresistance.